[PDF] Top 20 Exercise training and endothelial function in patients with type 2 diabetes: a meta-analysis

... type 2 diabetes, since on the one hand, every 1% increase in FMD was correlated with an estimated 13% risk reduc- tion of cardiovascular events based on the report from van Sloten and colleagues ... See full document

... aerobic exercise can increase insu- lin sensitivity, which improves the adverse lipid profile [73, ...resistance exercise can benefit all adults and patients with T2DM by improving physical ... See full document

... the training features and participants in some studies, such as the AT moda- lity and training status of participants, is another limi- ...present meta-analysis contributes novelty to the ... See full document

... between diabetes and endothelial function were often re- cruited from convenience samples like members of hos- pital staff, their relatives, or friends ...investigating endothelial ... See full document

... In the literature, vitamin D is related to gene expres- sion control which may trigger a biological response to oxidative stress, such as inhibiting nitric oxide synthase (iNOS) or increasing glutatione levels [66]. The ... See full document

... had patients with different kinds of diseases as well as T2D in the groups [25, 26], three had T2D patients with peripheral arterial disease or diabetic peripheral neuropathy [27–29], two did not provide ... See full document

... physical exercise in the elderly and in special populations (patients with diabetes, obesity, cardiovascular diseases, movement ...specific training programs for special ... See full document

... the patients with T2D in this study were receiving various anti-atherogenic drug interventions such as anti- hypertensive agents, statins and insulin therapy that can exert considerable effects on FMD of the ... See full document

... Chi training style, posture, frequency and ...vascular function, especially increasing the vascu- lar reactivity index [36, ...Such training might decrease the potential ... See full document

... and type of exercise that will most benefit this vulnerable ...of exercise, much of the literature is muddled by small subject size and heterogeneity of training intensity, volume, and ... See full document

... association. Large, well- designed randomized controlled trials are needed to address this issue adequately. Given the former, future randomized controlled trials may want to address some of the differences and ... See full document

... Type 2 diabetes is believed to be a chronic, pro- gressive, and multifactorial metabolic disease defined by the presence of chronic hyperglyce- mia ...American Diabetes Association rec- ... See full document

... Objectives: Endothelial dysfunction is a common feature of type 2 ...on endothelial function, beyond the well known homocysteine lowering ...determine endothelial-dependent ... See full document

... to exercise training, subjects were evaluated over the course of two separate ...or exercise training (ET) ...18 patients were randomly distributed into two groups (exercise or ... See full document

... Eligible patients were at least 30 years of age and who had type 2 diabetes with HbA1c level of ...diet, exercise and/or pharmacologic therapy with oral antihypergly- cemic agents ... See full document

... in diabetes patients ...in diabetes patients ...the Diabetes Epi- demiology Collaborative analysis of Diagnostic criteria in Europe (DECODE) study, have established that even a ... See full document

... vascular endothelial function in Japanese type 2 diabetes patients without cardiovascular ...Japanese type 2 diabetes pa- tients without cardiovascular ... See full document

... Maximal cardiopulmonary test. The aerobic capacity evaluation was per- formed by a cardiopulmonary treadmill (Centurion 200, Micromed) test, using a ramp protocol with increasing velocity and/or slope every minute in the ... See full document

... of type 2 diabetes mellitus (T2DM) and cardiometabolic risk has led to concerns over the future population burden of chronic heart and kidney ...however, patients with chronic kidney disease ... See full document

... Glucagon-like-peptid-1 (GLP-1) analogues are a group of drugs used in the treatment of type 2 diabetes. GLP-1 is an endogenous incretin hormone with pleiotropic metabolic effects [8]. GLP-1 analogues ... See full document